Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
CH0522213468
Wed, 25.08.2021
Achiko AG
Achiko's rapid Covid-19 diagnostic test AptameX(TM) receives product and registration approval from Indonesia's Ministry of Health
- AptameXTM, Achiko's breakthrough DNA aptamer-based diagnostic test for Covid-19, received product and registration emergency use approval from the Ministry of Health in Indonesia, alongside its sister digital passpor [ … ]
Thu, 15.07.2021
Achiko AG
Achiko engages EpiMetrics to expand Covid-19 testing operations with Udayana University in Bali, Indonesia in the implementation of a mass testing program
Zurich, 15 July 2021: Ad hoc announcement pursuant to Art. 53 LR - Achiko AG (SWX:ACHI, ISIN CH0522213468) ("Achiko", the "Company"), a global healthtech company currently developing technologie [ … ]
Fri, 18.06.2021
Achiko AG
Achiko announces an extension of its Convertible Loan Transaction with Negma Group
Zurich, 18 June 2021 - Achiko AG (SWX:ACHI, ISIN CH0522213468) ("Achiko", the "Company") has successfully extended the subordinated convertible loan agreement of CHF 900,000 dated 8 March 2021 to CHF 1,650,000 thereby granting Achiko an additional CHF 750,000 to be [ … ]
Thu, 03.06.2021
Achiko AG
Achiko announces the successful integration of its Teman Sehat digital ecosystem and AptameX Covid-19 diagnostic testing platform for launch in Indonesia
- Wireless integration of AptameX Covid-19 test with Teman Sehat completed
- Teman Sehat's open API allows for integration of third party testing platforms
- Teman Sehat provides results within [ … ]
Wed, 26.05.2021
Achiko AG
2021 Annual General Meeting of Achiko AG: Shareholders adopt all proposals
Zurich, 26 May 2021 - Achiko AG (SWX:ACHI, ISIN CH0522213468) ("Achiko" or the "Company") held its Annual General Meeting today at 10:00 CEST in Zurich. Due to the Covid-19 pandemic, this Annual General Meeting was held without physical presence of the shareholders in accor [ … ]
Thu, 20.05.2021
Achiko AG
Achiko completes initial shipment of AptameX, its progressive Covid-19 diagnostic test, to Indonesia, delivering 77% sensitivity at low viral loads
- Production of first 1,000 AptameX test kits is concluded in Singapore (initial capacity to test 10,000 patients per day).
- AptameX delivers sensitivity of 77% (95% CI: 75.94 - 79.24) at a high ind [ … ]
Tue, 04.05.2021
Achiko AG
Achiko appoints new Chief Financial Officer and announces changes to senior team
- Appoints Robert Rieder as Chief Financial Officer
- Chief Operating Officer Chris Young to retire
- Focus on product development, lowering cost profile and improved alignment of resources
Zurich, 4 May 2021 - Achiko AG (SWX:ACHI, ISIN CH0522213468) appoints Ro [ … ]
Thu, 29.04.2021
Achiko AG
Achiko's joint venture partner obtains a distribution certificate for AptameX, a novel diagnostic test for Covid-19 in Indonesia, and commences product registration
- Achiko AG's joint venture partner PT Indonesia Farma Medis (IFM) obtains medical device distribution certificate
- Achiko subsequently commenced product registration with its partn [ … ]
Wed, 28.04.2021
Achiko AG
Achiko AG Announces Annual Results for the Year Ended 31 December 2020
- 2020 was a year of audacity, determination, and transformation
- Expertise has been strengthened by a refocused Executive Committee and by establishing an Advisory Board
- The financial performance was characterised by the shift of strategy from fintech to healthtech
- Res [ … ]
Tue, 27.04.2021
Achiko AG
Achiko AG invites shareholders to its Annual General Meeting on 26 May 2021
- Annual General Meeting of shareholders to be held on 26 May 2021
- Due to the Covid-19 pandemic, the meeting will be held without physical presence of the shareholders
- John Bing-Tsung Lin to retire from the Board of Directors at the Annual General Meeting and Dr Jitt [ … ]